Previous studies indicated that IL-1β plays a vital role in the pathophysiology of cardiovascular diseases [9, 24], indicating that decrease IL-1β expression in smooth muscle cells decreases the production of atherosclerotic inflammatory factors and might prevent the progression of atherosclerosis. The gene discussed is IL1B; the disease is atherosclerosis.